positionForPages[11]={page:11,positions:[{word:"11",left:0.490967,top:0.945381,width:0.016177,height:0.016265},{word:"百靈佳殷格翰",left:0.449093,top:0.035100,width:0.100793,height:0.012378},{word:"!",left:0.596961,top:0.616616,width:0.007350,height:0.010831},{word:"!",left:0.602473,top:0.647571,width:0.007350,height:0.010831},{word:"!",left:0.898630,top:0.353707,width:0.007350,height:0.010831},{word:".",left:0.901173,top:0.369184,width:0.007350,height:0.010831},{word:"!",left:0.923001,top:0.756053,width:0.007350,height:0.010831},{word:"!",left:0.901335,top:0.833440,width:0.007349,height:0.010831},{word:"!",left:0.889972,top:0.910827,width:0.007350,height:0.010831},{word:"!",left:0.590336,top:0.230555,width:0.006719,height:0.009902},{word:"!",left:0.596938,top:0.290110,width:0.008399,height:0.012378},{word:"呼吸急促和久咳不癒通常是阻塞性",left:0.071429,top:0.524575,width:0.285719,height:0.013616},{word:"肺部疾病初期的徵兆。這個疾病非",left:0.071429,top:0.548403,width:0.285738,height:0.013616},{word:"常普遍，許多四十歲以上的人都受",left:0.071429,top:0.572231,width:0.285738,height:0.013616},{word:"到影響或者有罹病的高風險。估計",left:0.071429,top:0.596059,width:0.285738,height:0.013616},{word:"全球有兩億一千萬人罹患阻塞性肺",left:0.071429,top:0.619887,width:0.285719,height:0.013616},{word:"部疾病，因此比糖尿病更為普遍。",left:0.071429,top:0.643715,width:0.285714,height:0.013616},{word:"專家估計到二○三○年每三例死亡",left:0.071429,top:0.667543,width:0.285719,height:0.013616},{word:"中就有一例歸因於阻塞性肺部疾",left:0.071429,top:0.691371,width:0.285608,height:0.013616},{word:"病。這個病無法根治，但可以治療",left:0.071429,top:0.715199,width:0.285714,height:0.013616},{word:"改善症狀，逆轉疾病增加以及體能",left:0.071429,top:0.739027,width:0.285738,height:0.013616},{word:"活動日益不足的惡性循環危險。",left:0.071429,top:0.762855,width:0.258703,height:0.013616},{word:"為幫助患者，百靈佳殷格",left:0.131910,top:0.786683,width:0.225220,height:0.013616},{word:"翰與美國康乃爾醫學院（Weill  在美國發展，並從二○一四年起",left:0.071429,top:0.810511,width:0.572326,height:0.000899},{word:"Cornell）遺傳醫學系的研究員有了",left:0.071429,top:0.834339,width:0.285714,height:0.013616},{word:"全新的突破。他們攜手合作研究如",left:0.071429,top:0.858167,width:0.285738,height:0.013616},{word:"何阻止小氣道的退化，或許甚至予",left:0.071429,top:0.881995,width:0.285738,height:0.013616},{word:"以逆轉。這是這個病的核心病因之",left:0.071429,top:0.905823,width:0.285738,height:0.013616},{word:"一。康乃爾醫學院的專家對慢性",left:0.382390,top:0.380709,width:0.261365,height:0.013616},{word:"肺病有非常深入的理解，對肺病",left:0.382390,top:0.404537,width:0.261365,height:0.013616},{word:"的研究亦有非常豐富的經驗，百",left:0.382390,top:0.428365,width:0.261367,height:0.013616},{word:"靈佳殷格翰的研究小組則在發現",left:0.382390,top:0.452193,width:0.261346,height:0.013616},{word:"與研發新的呼吸道療法方面擁有",left:0.382390,top:0.476021,width:0.261346,height:0.013616},{word:"獨特的技術。「我們完全是相輔",left:0.382390,top:0.499848,width:0.261346,height:0.013616},{word:"相成，這個絕佳組合使我們得以",left:0.382390,top:0.523676,width:0.261365,height:0.013616},{word:"快速把科學新發現轉化為藥品的",left:0.382390,top:0.547504,width:0.261346,height:0.013616},{word:"研發。」克裡夫．伍德博士說。",left:0.382390,top:0.571332,width:0.261365,height:0.013616},{word:"探索研究部門企業資深副董事長",left:0.382390,top:0.595160,width:0.261346,height:0.013616},{word:"伍德基本上就是本公司人類處方",left:0.382390,top:0.618988,width:0.261346,height:0.013616},{word:"藥品研究的最高主管。",left:0.382390,top:0.642816,width:0.184788,height:0.013616},{word:"「學術研究的科學家與",left:0.442871,top:0.666644,width:0.200921,height:0.013616},{word:"本公司都有探索發現的熱忱，並",left:0.382390,top:0.690472,width:0.261367,height:0.013616},{word:"且共同努力把這些新發現轉化為",left:0.382390,top:0.714300,width:0.261346,height:0.013616},{word:"新藥品。」伍德道，並說明這樣",left:0.382390,top:0.738128,width:0.261439,height:0.013616},{word:"的合作何以前景看好。伍德在英",left:0.382390,top:0.761956,width:0.261365,height:0.013616},{word:"國成長求學，但職業生涯大都是",left:0.382390,top:0.785784,width:0.261365,height:0.013616},{word:"便在百靈佳殷格翰德國殷格翰總",left:0.382390,top:0.833440,width:0.261346,height:0.013616},{word:"公司工作。「當新的研究領域浮",left:0.382390,top:0.857268,width:0.261346,height:0.013616},{word:"現時，我們就在第一線，並且不",left:0.382390,top:0.881096,width:0.261346,height:0.013616},{word:"斷與外部專家密切交流。」",left:0.382390,top:0.904924,width:0.221746,height:0.013616},{word:"對百靈佳殷格翰而言，",left:0.729515,top:0.231736,width:0.199046,height:0.013616},{word:"這是「開放式創新」的最佳詮",left:0.669034,top:0.255564,width:0.259535,height:0.013616},{word:"釋。「我們在尋找未來的藥品，」",left:0.669034,top:0.279392,width:0.264143,height:0.013616},{word:"伍德說。「以開放的態度，接受",left:0.669034,top:0.303220,width:0.259442,height:0.013616},{word:"能激發研究與發展的最佳新觀點",left:0.669034,top:0.327048,width:0.259424,height:0.013616},{word:"與概念。我們在前進時一直留神",left:0.669034,top:0.350876,width:0.259590,height:0.013616},{word:"會出現創新的地方──不論是公",left:0.669034,top:0.374704,width:0.259424,height:0.013616},{word:"司內部或外部，而這就是我們為",left:0.669034,top:0.398532,width:0.259590,height:0.013616},{word:"創新建立理想搖籃的方式。",left:0.669034,top:0.422360,width:0.221746,height:0.013616},{word:"》當新的研究領域",left:0.669047,top:0.470020,width:0.188148,height:0.017329},{word:"浮現時，",left:0.669047,top:0.500346,width:0.094074,height:0.017330},{word:"我們就在第一線《",left:0.669047,top:0.530673,width:0.188148,height:0.017329},{word:"        2015 年，百靈佳殷格翰重",left:0.669047,top:0.570279,width:0.259539,height:0.013616},{word:"新制定開發研究的策略。研發新",left:0.669047,top:0.592555,width:0.259591,height:0.013616},{word:"藥自此被分為四個研究範疇：免",left:0.669047,top:0.616383,width:0.259591,height:0.013616},{word:"疫學與呼吸系統疾病、心血管代",left:0.669047,top:0.640211,width:0.259591,height:0.013616},{word:"謝疾病、腫瘤學、中樞神經系統",left:0.669047,top:0.664039,width:0.259517,height:0.013616},{word:"疾病。調節人體本身免疫系統的",left:0.669047,top:0.687867,width:0.259591,height:0.013616},{word:"能力為癌症的治療開闢了令人振",left:0.669047,top:0.711695,width:0.259424,height:0.013616},{word:"奮的新途徑，因此百靈佳殷格翰",left:0.669047,top:0.735523,width:0.259591,height:0.013616},{word:"的開發研究組織計畫進一步增加",left:0.669047,top:0.759351,width:0.259424,height:0.013616},{word:"腫瘤學方面的投資，額外增加一",left:0.669047,top:0.783179,width:0.259591,height:0.013616},{word:"個以免疫腫瘤學為主的治療研究",left:0.669047,top:0.807007,width:0.259424,height:0.013616},{word:"領域。百靈佳殷格翰並設立一些",left:0.669047,top:0.830835,width:0.259591,height:0.013616},{word:"包羅萬象的科學平臺，例如免疫",left:0.669047,top:0.854663,width:0.259591,height:0.013616},{word:"調節，把專業知識與資源集中於",left:0.669047,top:0.878491,width:0.259591,height:0.013616},{word:"能夠橫跨多種治療領域的範疇。",left:0.669047,top:0.902319,width:0.258704,height:0.013616},{word:"DR. CLIVE R. WOOD",left:0.446703,top:0.232745,width:0.130669,height:0.011008},{word:"───────",left:0.447356,top:0.238669,width:0.129352,height:0.013616},{word:"↓",left:0.502792,top:0.262497,width:0.018479,height:0.013616},{word:"是人類處方藥探索研究部門企業資",left:0.386040,top:0.286323,width:0.251984,height:0.012379},{word:"深副董事長",left:0.470035,top:0.307985,width:0.083994,height:0.012378},{word:"自 2014 年便任職百靈佳殷格翰",left:0.398639,top:0.329647,width:0.226786,height:0.012378}]};